Aplagon secures EUR 7 million for APAC phase 2a trials - PharmaTimes Funding led by new investors FSG and EIC Fund

#Aplagon #APACtherapeutic #thromboinflammatorydiseases #heparinproteoglycanmimetic #antiplatelet #anticoagulant #mastcellderivedheparinproteoglycans #antithrombotic #antiinflammatory #peripheralarterialocclusivedisease #chroniclimbthreateningischemia #PAOD #CLTI
pharmatimes.com/news/aplagon...